| Net Cash Provided by (Used in) Operating Activities |
$71,000,000 |
USD |
-61% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$-780,000,000 |
USD |
66.9% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$661,000,000 |
USD |
-71.6% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,125,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
467,000,000 |
shares |
0.43% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$-48,000,000 |
USD |
-131% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,872,000,000 |
USD |
-33% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$703,000,000 |
USD |
-18.8% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$-54,000,000 |
USD |
-238% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$9,000,000 |
USD |
-18.2% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$47,100,000 |
USD |
-2.89% |
Q4 2024 |
FY 2024 |
| Amortization of Intangible Assets |
$2,000,000 |
USD |
-33.3% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$302,000,000 |
USD |
-11.7% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$3,519,000,000 |
USD |
10% |
Q2 2024 |
Q2 2024 |